View Single Post
Old 07-06-2007, 09:57 AM
MelodyL's Avatar
MelodyL MelodyL is offline
Wise Elder
 
Join Date: Aug 2006
Posts: 8,292
15 yr Member
MelodyL MelodyL is offline
Wise Elder
MelodyL's Avatar
 
Join Date: Aug 2006
Posts: 8,292
15 yr Member
Default

Wow, isn't this interesting!!! I go to Cornell for their ACCORD protocol. Got my sugar under control and my A1c is down to 6.5. from 9.0 when I first began over two years ago, when my sugar was 400.

So now I hear of this Ranirestat.

I just got this off the internet.
--------------------------------------------------------------------------

The Phase III Trial
The Diabetic Sensorimotor Polyneuropathy (DSP) Trial at NewYork-Presbyterian/Weill Cornell will examine the safety and effectiveness of an investigational medication (Ranirestat) that is designed to slow the progression or possibly reverse the course of DSP.

Introductory testing will determine if a person actually has DSP, and those eligible for the trial will be asked to make 14 visits over the course of one year. Five of the 14 visits will include nerve conduction tests to determine if a patient's condition is improving, worsening, or staying the same. Participants are required to take a daily dose of the investigational medication (Ranirestat) or a placebo. Medication is given orally, and participants have a 3 in 4 chance of receiving the investigational medication. All participants may continue taking their other medications. Testing and medication is provided free of charge.

To be eligible for the trial, patients should:

Have either type I or type II diabetes
Be between 18 and 70 years old
Have a hemoglobin A1c ≥ 7.0%, despite attempts to optimize glycemic control
Have creatinine levels of < 2.0 mg/dL
Have normal AST and ALT, and alkaline phosphate < 2x normal
Patients who are or intend to become pregnant; patients who are nursing; patients with Hepatitis B, C, or HIV infection; or those with neuropathy from causes other than diabetes are not eligible.

The Diabetic Sensorimotor Polyneuropathy (DSP) Trial is being sponsored by Dainippon Pharmaceutical Co., Ltd., Japan, and is taking place at 26 sites throughout North America.

-------------------------------------------------------------------------

I couldn't keep my Cornell appointment today because I have a cold a chest congestion and I can't do the two hours back and forth with the Access-a-ride to get to Cornell.

My new appointment is July 20. You better believe I will question this Phase 3 trial thing. I don't qualify because my A1c is good. I'm not complaining.

And I take my Methyl B-12.

But what exactly is Ranerestat?? How do they make it?? Is it from venom, or is it another anti-seizure med?? I did read that it prevents the build up of Sorbitol in the body, which contributes to neuropathy.

Now is this the same Sorbitol that is an artificial sweetner?? Thank god, that I don't use this stuff. It used to give me the runs, so I stopped using anything with Sorbitol years and years ago. Haven't touched it since.

I wonder if many diabetics who use sorbitol and get neuropathy, well, whether it makes it worse??? It's a good question, no???

Melody
__________________

.


CONSUMER REPORTER
SPROUT-LADY



.
MelodyL is offline   Reply With QuoteReply With Quote